Condition
Organ Donor
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03098706Not ApplicableCompletedPrimary
Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function
NCT06734091Not ApplicableRecruiting
Rapid Processing and Immunohistochemistry Method for Optimising Diagnosis Time in Solid Organ Donors, Suspected Malignancy
NCT06611046Completed
MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors.
NCT00310401Phase 2Completed
The Effect of Nebulized Albuterol on Donor Oxygenation
NCT01009125Not ApplicableCompletedPrimary
Healthcare Access and Utilization Among Living Kidney Donors
Showing all 5 trials